Journal article
Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age
Archives of disease in childhood. Fetal and neonatal edition, Vol.98(2), pp.F127-47
03/2013
DOI: 10.1136/archdischild-2011-300659
PMCID: PMC3753803
PMID: 22684157
Abstract
Background Spontaneous intestinal perforation (SIP) is associated with the use of postnatal glucocorticoids and indometacin in extremely low birth weight (ELBW) infants. The authors hypothesised: 1) an association of SIP with the use of antenatal steroids (ANS) and indometacin either as prophylaxis for intraventricular hemorrhage (IVH) (P Indo) or for treatment of PDA (Indo/PDA) and 2) an increased risk of death or abnormal neurodevelopmental outcomes in infants with SIP at 18–22 months corrected age. Design/Methods The authors retrospectively identified ELBW infants with SIP in the Neonatal Research Network's generic database. Unadjusted analysis identified the differences in maternal, neonatal and clinical variables between infants with and without SIP. Logistic regression analysis identified the adjusted OR for SIP with reference to ANS, P Indo and Indo/PDA. Neurodevelopmental outcomes were assessed among survivors at 18–22 months corrected age. Results Indo/PDA was associated with an increased risk of SIP (adjusted OR 1.61; 95% CI 1.25 to 2.08), while P Indo and ANS were not. SIP was independently associated with an increased risk of death or neurodevelopmental impairment (NDI) (adjusted OR 1.85; 95% CI 1.32 to 2.60) and NDI among survivors (adjusted OR 1.75, 95% CI 1.20 to 2.55). Conclusion Indometacin used for IVH prophylaxis and ANS were not associated with the occurrence of SIP in ELBW infants. Indometacin used for treatment of symptomatic PDA was however associated with an increased risk of SIP. ELBW infants with SIP have an increased risk of poor neurodevelopmental outcomes.
Details
- Title: Subtitle
- Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age
- Creators
- Rajan Wadhawan - Division of Neonatology, All Children's Hospital, St Petersburg, Florida, USAWilliam Oh - Department of Pediatrics, Women & Infants Hospital, Providence, Rhode Island, USABetty R Vohr - Department of Pediatrics, Women & Infants Hospital, Providence, Rhode Island, USAShampa Saha - Department of Statistics and Epidemiology, Research Triangle Institute, Research Triangle Park, North Carolina, USAAbhik Das - RTI International, Rockville, Maryland, USAEdward F Bell - Department of Pediatrics, University of Iowa, Iowa city, Iowa, USAAbbott Laptook - Department of Pediatrics, Women & Infants Hospital, Providence, Rhode Island, USASeetha Shankaran - Department of Pediatrics, Wayne State UniversityChildrens Hospital of Michigan, Detroit, Michigan, USABarbara J Stoll - Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USAMichele C Walsh - Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USARose Higgins - Eunice Kennedy Shiver National Institute of Child Health and Human Development, Bethesda, Maryland, USA
- Resource Type
- Journal article
- Publication Details
- Archives of disease in childhood. Fetal and neonatal edition, Vol.98(2), pp.F127-47
- DOI
- 10.1136/archdischild-2011-300659
- PMID
- 22684157
- PMCID
- PMC3753803
- NLM abbreviation
- Arch Dis Child Fetal Neonatal Ed
- ISSN
- 1359-2998
- eISSN
- 1468-2052
- Language
- English
- Date published
- 03/2013
- Academic Unit
- Stead Family Department of Pediatrics; Neonatology
- Record Identifier
- 9984093596702771
Metrics
11 Record Views